Q2 2022 Holdings
Filed 2022-08-15 | 131 holdings | $674.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $132.6M | 350,000 | 19.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $83.9M | 354,500 | 12.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $64.9M | 2,928,458 | 9.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $54.8M | 3,927,149 | 8.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $51.0M | 753,500 | 7.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $48.5M | 332,500 | 7.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $39.6M | 425,500 | 5.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $21.9M | 264,500 | 3.2% |
| Conmed Corp(CNMD) | COM | 207410101 | $21.4M | 223,000 | 3.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $18.8M | 974,107 | 2.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $15.7M | 400,000 | 2.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $15.5M | 1,461,091 | 2.3% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $14.3M | 1,008,814 | 2.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $14.1M | 5,328,088 | 2.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $13.0M | 1,085,740 | 1.9% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $12.8M | 725,000 | 1.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $11.8M | 280,100 | 1.7% |
| Azenta Inc(AZTA) | COM | 114340102 | $11.7M | 162,000 | 1.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $9.0M | 335,477 | 1.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $8.2M | 815,126 | 1.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $4.3M | 111,430 | 0.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $4.0M | 2,357,544 | 0.6% |
| Humana Inc(HUM) | COM | 444859102 | $199.6K | 426,358 | 0.0% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $167.7K | 7,681,000 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $137.9K | 268,500 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $109.4K | 1,122,500 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $109.4K | 502,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $99.7K | 2,671,652 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $84.1K | 2,738,000 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $78.5K | 223,750 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $65.2K | 1,093,030 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $64.6K | 1,174,786 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $59.9K | 298,500 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $59.5K | 746,000 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $59.3K | 1,017,500 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $57.2K | 602,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $56.7K | 844,977 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $55.9K | 441,893 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $50.0K | 401,500 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $49.5K | 979,174 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $48.1K | 272,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $46.7K | 1,767,141 | 0.0% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $46.0K | 240,500 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $45.1K | 701,600 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $42.2K | 1,215,900 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $35.2K | 472,800 | 0.0% |
| Covetrus Inc(CVETUSD) | COM | 22304C100 | $34.8K | 1,678,800 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $34.2K | 1,123,604 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $33.9K | 773,300 | 0.0% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $33.6K | 111,000 | 0.0% |